As of August 28, 2026, Enanta Pharmaceuticals, Inc. (ENTA) has a DilutionWatch DilutionScore of 29/100, rated MEDIUM dilution risk. Enanta Pharmaceuticals, Inc. has a market capitalization of $382.67M, 29.13M shares outstanding, 133 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for ENTA.
Market Data
Market Cap$382.67M
Shares Outstanding29.13M
Float20.06M
Cash$227.09M
Debt$186.62M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 15.2% shares (2026Q1 vs prior)
133 institutional holders · 33.15M shares
#1
JANUS HENDERSON GROUP PLC
7.57M shares
#2
BlackRock, Inc.
3.10M shares
#3
FARALLON CAPITAL MANAGEMENT LLC
2.87M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest2.59M
Days to Cover17.7
% of Float12.9%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2013-09-30
Form 4
INSIDER TRANSACTION
2026-08-08
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual ENTA Dilution Snapshot
Enanta Pharmaceuticals, Inc. (ENTA) has a DilutionScore of 29/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for ENTA: Form 4 on 2026-08-08; xbrl on 2013-09-30.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track ENTA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ENTA — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for ENTA
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.